文献速递疝与腹壁外科

术前A型肉毒毒素辅助复杂腹壁疝缺损闭合与腹腔镜修补

Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia.
PubMed 文献 · Surg Endosc · 2017-07-21

该前瞻性观察研究纳入56例复杂腹壁疝患者,术前超声引导下向腹斜肌注射A型肉毒毒素(BTA),以促进缺损闭合和腹腔镜修补。BTA注射耐受良好,腹壁侧方长度平均每侧增加4.0 cm(p<0.0001),所有病例均实现腹腔镜或LOL下原发闭合,无腹腔内压升高证据。结论认为术前BTA是复杂腹壁疝术前准备的安全有效技术。

要点

  • 术前BTA注射可松弛、延长并变薄慢性收缩的腹壁肌肉,降低侧方牵引力。
  • 56例患者均实现腹腔镜或LOL下原发筋膜闭合,无腹腔内压升高临床证据。
  • BTA注射耐受良好,仅1例术后26个月出现新发筋膜缺损。

核心结论

  • 术前向腹壁侧方肌肉注射BTA是复杂腹壁疝术前准备的安全有效技术,可促进腹腔镜修补和筋膜闭合。

研究设计与样本

  • 前瞻性观察研究,纳入2012年11月至2017年1月期间56例择期腹壁疝修补术前接受超声引导下腹斜肌BTA注射的患者。
  • 所有疝均采用腹腔镜或腹腔镜-开放-腹腔镜(LOL)联合腹腔内补片修补。
  • 18例患者额外接受术前人工气腹作为辅助措施。

主要发现

  • BTA注射在预定部位进行,耐受良好;患者平均年龄59.7岁,平均BMI 30.9 kg/m2(范围21.8-54.0)。
  • 最大缺损尺寸为24 × 27 cm。
  • BTA注射前后影像比较显示腹壁侧方平均长度从16.1 cm增至20.1 cm每侧,平均每侧增加4.0 cm(范围1.0-11.7 cm/侧)(p < 0.0001)。
  • 对应腹壁侧方未拉伸平均长度增加8.0 cm。
  • 所有病例实现腹腔镜/LOL原发闭合,无腹腔内压升高的临床证据;1例术后26个月出现新发筋膜缺损。

临床怎么用

  • 对复杂腹壁疝伴巨大缺损、腹壁肌肉慢性收缩患者,可考虑术前超声引导下腹斜肌BTA注射以辅助缺损闭合和腹腔镜修补。
  • BTA注射后可通过系列腹部CT评估腹壁侧方肌肉长度和厚度变化。

局限性

  • 本研究为前瞻性观察研究,非随机对照,样本量56例,结论需更高质量研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Operative management of complex ventral hernia still remains a significant challenge for surgeons. Closure of large defects in the unprepared abdomen has serious pathophysiological consequences due to chronic contraction and retraction of the lateral abdominal wall muscles. We report outcomes of 56 consecutive patients who had preoperative Botulinum toxin A (BTA) abdominal wall relaxation facilitating closure and repair. METHODS: This was a prospective observational study of 56 patients who underwent ultrasound-guided BTA into the lateral abdominal oblique muscles prior to elective ventral hernia repair between November 2012 and January 2017. Serial non-contrast abdominal CT imaging was performed to evaluate changes in lateral oblique muscle length and thickness. All hernias were repaired laparoscopically, or laparoscopic-open-laparoscopic (LOL) using intraperitoneal onlay mesh. RESULTS: 56 patients received BTA injections at predetermined sites to the lateral oblique muscles, which were well tolerated. Mean patient age was 59.7 years, and mean BMI was 30.9 kg/m2 (range 21.8-54.0). Maximum defect size was 24 × 27 cm. A subset of 18 patients underwent preoperative pneumoperitoneum as an adjunct procedure. A comparison of pre-BTA to post-BTA imaging demonstrated an increase in mean lateral abdominal wall length from 16.1 cm to 20.1 cm per side, a mean gain of 4.0 cm/side (range 1.0-11.7 cm/side) (p < 0.0001). This corresponds to an unstretched mean length gain of 8.0 cm of the lateral abdominal wall. Laparoscopic/LOL primary closure was achieved in all cases, with no clinical evidence of raised intra-abdominal pressures. One patient presented with a new fascial defect 26 months post-operative. CONCLUSION: Preoperative BTA to the lateral abdominal wall muscles is a safe and effective technique for the preparation of patients prior to operative management of complex ventral hernias. BTA temporary flaccid paralysis relaxes, elongates and thins the chronically contracted abdominal musculature. This in turn reduces lateral traction forces facilitating laparoscopic repair and fascial closure of large defects under minimal tension.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, et al. Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2017. PMID: 28733748. doi:10.1007/s00464-017-5750-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。